Department of Legal Medicine, Psychiatry and Pathology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Department of Pathology, Hospital Clínico San Carlos, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain.
Am J Clin Pathol. 2024 Feb 1;161(2):186-196. doi: 10.1093/ajcp/aqad119.
Several alternative lymph node staging systems have recently been described for gastric cancer. The log odds of positive lymph nodes (LODDS) system may be superior to the pN stage (American Joint Committee on Cancer) and lymph node ratio systems in predicting outcomes for patients with gastric cancers, as indicated by some researchers. Most studies, however, have been conducted in Asian countries, and conflicting results have been reported by other investigators.
We conducted a retrospective study of all 377 cases of gastric cancer resected at a tertiary hospital in Spain between 2000 and 2019. Clinicopathologic features were collected, LODDS were calculated and categorized into 5 groups (S1-S5), and statistical analysis was performed.
The cases included (n = 315) were classified as S1 (25.6%), S2 (18.4%), S3 (21.3%), S4 (20.3%), and S5 (14.4%). The LODDS classification was significantly associated with tumor size, Laurén subtype, presence of signet ring cells, tumor grade, perineural infiltration, lymphovascular invasion, growth pattern, pT, tumor recurrence, and death. Kaplan-Meier analysis based on the LODDS classification demonstrated improved patient stratification compared with the pN stage for both overall survival (OS) and disease-free survival (DFS). Area under the curve values for recurrence and death were superior for the LODDS classification, and this classification was independently related to OS and DFS. In addition, the LODDS classification successfully divided patients without lymph node metastases (pN0) into subgroups with distinct prognoses.
For our cohort, the LODDS system showed better prognostic performance than pN stage; it was an independent predictor of OS and DFS, and it provided valuable prognostic information in cases without lymph node metastases. Its prognostic accuracy, however, decreased in cases with fewer than 16 lymph nodes resected.
最近已经描述了几种用于胃癌的替代淋巴结分期系统。一些研究人员指出,与美国癌症联合委员会的 pN 分期和淋巴结比率系统相比,对数阳性淋巴结(LODDS)系统可能更能预测胃癌患者的预后。然而,大多数研究都是在亚洲国家进行的,其他研究人员报告了相互矛盾的结果。
我们对 2000 年至 2019 年期间在西班牙一家三级医院接受手术切除的 377 例胃癌患者进行了回顾性研究。收集临床病理特征,计算 LODDS 并分为 5 组(S1-S5),并进行统计学分析。
包括(n=315)在内的病例被分类为 S1(25.6%)、S2(18.4%)、S3(21.3%)、S4(20.3%)和 S5(14.4%)。LODDS 分类与肿瘤大小、Laurén 亚型、印戒细胞存在、肿瘤分级、神经周围浸润、血管淋巴管浸润、生长模式、pT、肿瘤复发和死亡显著相关。基于 LODDS 分类的 Kaplan-Meier 分析显示,与 pN 分期相比,患者分层得到了改善,在总生存(OS)和无病生存(DFS)方面均有改善。对于复发和死亡,LODDS 分类的曲线下面积值更高,并且该分类与 OS 和 DFS 独立相关。此外,LODDS 分类成功地将无淋巴结转移(pN0)的患者分为具有不同预后的亚组。
对于我们的队列,LODDS 系统显示出比 pN 分期更好的预后性能;它是 OS 和 DFS 的独立预测因子,并为无淋巴结转移的病例提供了有价值的预后信息。然而,在切除的淋巴结少于 16 个的情况下,其预后准确性降低。